BDD Pharma Unveils New GMP Facility After Funding Boost
Deal News | Apr 08, 2025 | Scottish Enterprise
Leading contract research company BDD Pharma has inaugurated its new 122m² Good Manufacturing Practice (GMP) manufacturing facility, marking a significant milestone in its operational capabilities. This new facility, located at BioCity near Glasgow, marks a strategic expansion intended to enhance BDD's production capacities and support its research endeavors. The development follows a successful inspection by the Medicines and Healthcare products Regulatory Authority (MHRA), affirming its compliance with stringent regulatory standards. The expansion was made possible through £2 million in funding facilitated by Scottish Enterprise, highlighting the latter's commitment to fostering growth and innovation within the pharmaceutical sector. With this new facility, BDD Pharma aims to bolster its contract research offerings, improving the efficiency and quality of its drug development processes.
Sectors
- Pharmaceuticals
- Contract Research
Geography
- United Kingdom – The article centers on events taking place in the United Kingdom, specifically mentioning Glasgow as the location of BDD Pharma's new facility.
- Scotland – The new BDD Pharma facility is located in BioCity near Glasgow, Scotland, and involves Scottish Enterprise's funding, marking Scotland's role in this development.
Industry
- Pharmaceuticals – The article discusses BDD Pharma, a company within the pharmaceutical industry, specifically highlighting its contract research and GMP manufacturing capabilities.
- Contract Research – BDD Pharma operates as a contract research organization, which is a key focus in the article, especially with the launch of their new manufacturing facility.
Financials
- £2 million – The amount provided by Scottish Enterprise as funding for the expansion of BDD Pharma's facilities.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| BDD Pharma | Target Company | Company | BDD Pharma is a leading contract research company responsible for opening the new GMP manufacturing facility. |
| Scottish Enterprise | Investor | PE Firm | Scottish Enterprise funded the £2 million for the development of BDD Pharma's new facility. |
| Medicines and Healthcare Products Regulatory Authority (MHRA) | Regulator | Government | MHRA conducted the inspection that verified the compliance of BDD Pharma's new facility with regulatory standards. |